Abstract
Doctors Tsivian and Tsivian commented on the results of our randomized clinical trial, evaluating oncological and functional outcomes of simultaneous transurethral prostate (TURP) and bladder tumor resection (TURBT) in men with concomitant benign prostatic hyperplasia (BPH) with surgical indication (1). First of all, we would like to thank them for their insightful editorial comment which was recently published in this journal (2).
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
